Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?
Published . Updated .
Both of these biotech stocks could be appealing to income investors.
Directly affected
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AMGN | -3.25% | -0.21% | base | after close | after close | after close | after close |
| GILD | -1.91% | -1.58% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? The Motley Fool
Source: The Motley Fool
This story
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | three days earlier | -0.21% | final price |
| AMGN | five days earlier | -3.25% | final price |
| GILD | three days earlier | -1.58% | final price |
| GILD | five days earlier | -1.91% | final price |
| GLD | three days earlier | +3.37% | final price |
| GLD | five days earlier | +3.56% | final price |
| QQQ | three days earlier | +2.99% | final price |
| QQQ | five days earlier | +2.00% | final price |
| SPY | three days earlier | +1.75% | final price |
| SPY | five days earlier | +0.89% | final price |
| TLT | three days earlier | -1.35% | final price |
| TLT | five days earlier | -2.31% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 33 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 60 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 74 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 76 days before publication. Filed 4 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?” scores 12 out of 100. The score uses 1 sources.